ZNF610 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.184220E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.799200E-01
Normal-vs-Stage2
9.815800E-02
Normal-vs-Stage3
1.475270E-03
Normal-vs-Stage4
4.248600E-01
Stage1-vs-Stage2
8.455900E-02
Stage1-vs-Stage3
7.833700E-02
Stage1-vs-Stage4
7.640600E-01
Stage2-vs-Stage3
1.881230E-01
Stage2-vs-Stage4
3.282800E-01
Stage3-vs-Stage4
5.111600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.029040E-01
Normal-vs-AfricanAmerican
1.052990E-01
Normal-vs-Asian
4.127600E-01
Caucasian-vs-AfricanAmerican
7.732600E-01
Caucasian-vs-Asian
8.436000E-01
AfricanAmerican-vs-Asian
7.690600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.775800E-02
Normal-vs-Female
1.550630E-01
Male-vs-Female
7.634800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.584200E-01
Normal-vs-Age(41-60Yrs)
1.369550E-01
Normal-vs-Age(61-80Yrs)
7.955800E-02
Normal-vs-Age(81-100Yrs)
3.489000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.311240E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.197900E-02
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.606200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.324000E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.465400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.171600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.710000E-02
Normal-vs-Daily Drinker
3.712000E-02
Normal-vs-Weekly Drinker
4.537400E-03
Normal-vs-Occasional Drinker
2.920000E-01
Normal-vs-Social Drinker
7.894400E-02
Non Drinker-vs-Daily Drinker
5.128800E-01
Non Drinker-vs-Weekly Drinker
3.745000E-01
Non Drinker-vs-Occasional Drinker
2.284000E-01
Non Drinker-vs-Social Drinker
8.278200E-01
Daily Drinker-vs-Weekly Drinker
7.829400E-01
Daily Drinker-vs-Occasional Drinker
9.111500E-02
Daily Drinker-vs-Social Drinker
4.305400E-01
Weekly Drinker-vs-Occasional Drinker
6.113900E-02
Weekly Drinker-vs-Social Drinker
2.721400E-01
Occasional Drinker-vs-Social Drinker
3.835600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.467210E-01
Normal-vs-Grade 2
3.026400E-02
Normal-vs-Grade 3
5.972200E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.960400E-01
Grade 1-vs-Grade 3
5.252000E-01
Grade 1-vs-Grade 4
1.467210E-01
Grade 2-vs-Grade 3
6.684000E-01
Grade 2-vs-Grade 4
3.026400E-02
Grade 3-vs-Grade 4
5.972200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.363900E-02
Normal-vs-NonDiabetic
1.160610E-01
Diabetic-vs-NonDiabetic
4.995000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.862700E-03
Normal-vs-NoPancreatitis
1.047430E-01
Pancreatitis-vs-NoPancreatitis
3.470000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.065410E-01
Normal-vs-N1
1.102430E-01
N0-vs-N1
6.251800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.130600E-01
Normal-vs-TP53-NonMutant
2.327400E-01
TP53-Mutant-vs-TP53-NonMutant
4.317600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
